Drug Trial Radar · NCT04460872
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
Last checked: Nov 20, 2026Latest source record: May 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
21
Planned (sponsor's estimate)
Start
Jan 31, 2021
Primary completion
Jan 30, 2026
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- North Florida Foundation for Research and EducationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- North Florida/South Georgia Veterans Health System; Brooks Rehabilitation; University of Florida; VA Eastern Colorado Health Care System
- First posted
- Jul 8, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This pilot study will determine the feasibility of implementing a combinatory rehabilitation strategy involving testosterone replacement therapy (TRT) with locomotor training (LT; walking on a treadmill with assistance and overground walking) in men with testosterone deficiency and walking dysfunction after incomplete or complete spinal cord injury. The investigators hypothesize that LT+TRT treatment will improve muscle size and bone mineral density in men with low T and ambulatory dysfunction after incomplete or complete SCI, along with muscle fundtion and walking recovery in men with T low and ambulatory dysfunction ater incomplete SCI.
Conditions
- Spinal Cord Injury
- Spinal Cord Injuries
- Trauma, Nervous System
- Wounds and Injury
- Central Nervous System Diseases
- Spinal Cord Diseases
- Gonadal Disorders
- Endocrine System Diseases
- Hypogonadism
- Genital Diseases, Male
- Spinal Cord Trauma
- Injuries, Spinal Cord
- Walking, Difficulty
- Gait Disorders, Neurologic
- Locomotion Disorder, Neurologic
- Wounds and Injuries
- Nervous System Diseases
- Testosterone Deficiency
- Androgen Deficiency
- Hormone Deficiency
Interventions
Testosterone EnanthateDrug
Subjects receive testosterone (100 mg/week) by intramuscular injection
Locomotor TrainingBehavioral
Subjects receive locomotor training (4 sessions/week for 2-3 months)
Primary outcomes
What the sponsor says the trial is designed to measure.
- change in thigh muscle cross-sectional areaTime frame: baseline, 3 months, 6 months
- change in 6 min walk test (6MWT)Time frame: baseline, 1 month, 3 months, 6 months
- change in distal femur bone mineral densityTime frame: baseline, 3 months, 6 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
North Florida/South Georgia Veterans Health System
Gainesville, Florida · Recruiting
Brooks Rehabilitation
Jacksonville, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.